| 000 | 00858 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518015629.0 | ||
| 264 | 0 | _c20200602 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(18)30829-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKasenda, Benjamin | |
| 245 | 0 | 0 |
_aCNS border posts against rituximab? _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c02 2019 |
||
| 300 |
_a169-170 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aCentral Nervous System Neoplasms |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphoma, Non-Hodgkin |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aIllerhaus, Gerald | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 2 _gp. 169-170 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(18)30829-5 _zAvailable from publisher's website |
| 999 |
_c29242043 _d29242043 |
||